RegistryReach
← Insights
The league table

Who paid U.S. physicians the most in 2025

RegistryReach · July 2026 · Source: CMS Open Payments, program year 2025 (general payments)

Under the Sunshine Act, every payment a drug or device maker sends to a U.S. physician is public record. In program year 2025, manufacturers reported $2.89 billion in general payments to 1,020,608 providers. That's consulting fees, speaking engagements, meals, travel, royalties, and honoraria, itemized company by company, name by name.

Roll it up by paying company and the table has a clear winner, but the more interesting story is the mix.

The top ten

Top ten manufacturers by 2025 general payments
#Manufacturer2025 general payments
1AbbViePharma$198M
2StrykerDevice$121M
3MedtronicDevice$107M
4ArthrexDevice$105M
5Boston ScientificDevice$90M
6Zimmer BiometDevice$79M
7DePuy SynthesDevice$62M
8Novo NordiskPharma$58M
9Intuitive SurgicalDevice$57M
10AstraZenecaPharma$52M
General payments only (consulting, speaking, meals, travel, royalties). Research payments and ownership interests are reported separately by CMS and aren't included here.

AbbVie leads the league at $198M, well clear of second place. With an immunology and aesthetics portfolio that touches dermatology, gastroenterology, and rheumatology, its payment footprint is the widest in pharma.

But look at the column of chips: seven of the top ten are device companies. Stryker, Medtronic, Arthrex, Boston Scientific, Zimmer Biomet, DePuy Synthes, and Intuitive Surgical together reported over $620M, more than double the pharma names on the list. Device money concentrates hard in the operating room, which is why orthopaedic surgery tops the specialty table at $333M and why neurological surgery punches far above its headcount.

The geography follows the same logic. Payments per paid provider peak in Minnesota, home of Medtronic, at roughly $6,000 per provider, a per-capita picture you can flip to on the money map.

Novo Nordisk at #8 is the one to watch. GLP-1 launches put it among the fastest risers, and the 2026 data (published mid-2027) will show whether that climb continues.

Look it up yourself

Every figure here comes from the federal Open Payments release, joined against the national provider registry. The interactive money map breaks the same data down by state and specialty, and each specialty page shows exactly which manufacturers pay it.

Need the provider names behind these numbers?
Build a list of providers in any state and specialty, ranked by what these manufacturers actually paid them, with verified practice contacts. Preview counts free.
Build a provider list →